AG˹ٷ

STOCK TITAN

[144] Neuronetics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Neuronetics, Inc. (STIM) filed a Form 144 reporting a proposed sale of 192,806 common shares with an aggregate market value of $717,238.32. The filing states the sale is expected on or about 08/08/2025 on NASDAQ and lists Morgan Stanley Smith Barney LLC as the broker. The shares were acquired on 12/10/2024 in a merger/acquisition transaction from the issuer and were paid for in cash. The filing reports 66,124,820 shares outstanding and notes Nothing to Report for sales in the past three months.

Neuronetics, Inc. (STIM) ha presentato un Form 144 segnalando la proposta vendita di 192,806 azioni ordinarie per un valore complessivo di $717,238.32. La comunicazione indica che la vendita è prevista il o intorno al 08/08/2025 su NASDAQ e indica Morgan Stanley Smith Barney LLC come broker. Le azioni sono state acquisite il 12/10/2024 in una transazione di fusione/acquisizione dall'emittente e sono state pagate in contanti. Il modulo riporta 66,124,820 azioni in circolazione e segnala Niente da segnalare per vendite nei tre mesi precedenti.

Neuronetics, Inc. (STIM) presentó un Form 144 informando sobre la venta propuesta de 192,806 acciones ordinarias con un valor agregado de $717,238.32. El documento indica que la venta se espera en o alrededor del 08/08/2025 en la NASDAQ y nombra a Morgan Stanley Smith Barney LLC como corredor. Las acciones se adquirieron el 12/10/2024 en una transacción de ڳܲó/ܾó del emisor y fueron pagadas en efectivo. El informe registra 66,124,820 acciones en circulación y anota Nada que reportar por ventas en los últimos tres meses.

Neuronetics, Inc. (STIM)은 Form 144� 제출하여 � 시가총액 $717,238.32� 해당하는 192,806 보통주를 매도� 예정임을 보고했습니다. 신고서에� 해당 매도가 08/08/2025NASDAQ에서 이루어질 것으� 예상되며 중개인으� Morgan Stanley Smith Barney LLC가 기재되어 있습니다. 해당 주식은 12/10/2024� 발행사로부� 병/인수 거래� 취득되었� ˳금으로 지급되었습니다. 신고서에� 66,124,820주의 유통주식수가 보고되어 있으� 최근 3개월 � 매도� 대해서� 보고� 사항 없음으로 기재되어 있습니다.

Neuronetics, Inc. (STIM) a déposé un Form 144 signalant la vente proposée de 192,806 actions ordinaires pour une valeur totale de $717,238.32. Le dépôt indique que la vente est prévue aux alentours du 08/08/2025 sur le NASDAQ et désigne Morgan Stanley Smith Barney LLC comme courtier. Les actions ont été acquises le 12/10/2024 lors d'une opération de fusion/acquisition auprès de l'émetteur et ont été réglées en è. Le dossier indique 66,124,820 actions en circulation et mentionne Rien à signaler pour des ventes au cours des trois derniers mois.

Neuronetics, Inc. (STIM) hat ein Form 144 eingereicht, das einen geplanten Verkauf von 192,806 Stammaktien mit einem Gesamtmarktwert von $717,238.32 meldet. Die Einreichung gibt an, dass der Verkauf voraussichtlich am oder um den 08/08/2025 an der NASDAQ stattfinden wird und nennt Morgan Stanley Smith Barney LLC als Broker. Die Aktien wurden am 12/10/2024 im Rahmen einer ܲDz/ÜԲ󳾱-Transaktion vom Emittenten erworben und in Bar bezahlt. Das Formular verzeichnet 66,124,820 ausstehende Aktien und vermerkt Nichts zu melden für Verkäufe in den letzten drei Monaten.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine Form 144 disclosure; proposed sale disclosed and appears limited in size.

The Form 144 provides standard Section 144 disclosure of a proposed sale of 192,806 shares valued at $717,238.32. It notes the shares were acquired on 12/10/2024 in a merger/acquisition and paid in cash. The filing identifies the executing broker and an approximate sale date of 08/08/2025. There are no reported sales in the prior three months. Based solely on the filing, this is a routine notification meeting Rule 144 requirements.

TL;DR: Disclosure aligns with Rule 144; no immediate governance concerns evident from this notice.

The notice documents provenance of the shares (acquired from the issuer in a merger/acquisition) and includes the required representations about material nonpublic information. The broker and expected execution venue are specified. Because the filing contains no additional disclosures of insider transactions or recent sales, it does not by itself indicate governance issues. The filing should be viewed as a compliance disclosure tied to a planned sale.

Neuronetics, Inc. (STIM) ha presentato un Form 144 segnalando la proposta vendita di 192,806 azioni ordinarie per un valore complessivo di $717,238.32. La comunicazione indica che la vendita è prevista il o intorno al 08/08/2025 su NASDAQ e indica Morgan Stanley Smith Barney LLC come broker. Le azioni sono state acquisite il 12/10/2024 in una transazione di fusione/acquisizione dall'emittente e sono state pagate in contanti. Il modulo riporta 66,124,820 azioni in circolazione e segnala Niente da segnalare per vendite nei tre mesi precedenti.

Neuronetics, Inc. (STIM) presentó un Form 144 informando sobre la venta propuesta de 192,806 acciones ordinarias con un valor agregado de $717,238.32. El documento indica que la venta se espera en o alrededor del 08/08/2025 en la NASDAQ y nombra a Morgan Stanley Smith Barney LLC como corredor. Las acciones se adquirieron el 12/10/2024 en una transacción de ڳܲó/ܾó del emisor y fueron pagadas en efectivo. El informe registra 66,124,820 acciones en circulación y anota Nada que reportar por ventas en los últimos tres meses.

Neuronetics, Inc. (STIM)은 Form 144� 제출하여 � 시가총액 $717,238.32� 해당하는 192,806 보통주를 매도� 예정임을 보고했습니다. 신고서에� 해당 매도가 08/08/2025NASDAQ에서 이루어질 것으� 예상되며 중개인으� Morgan Stanley Smith Barney LLC가 기재되어 있습니다. 해당 주식은 12/10/2024� 발행사로부� 병/인수 거래� 취득되었� ˳금으로 지급되었습니다. 신고서에� 66,124,820주의 유통주식수가 보고되어 있으� 최근 3개월 � 매도� 대해서� 보고� 사항 없음으로 기재되어 있습니다.

Neuronetics, Inc. (STIM) a déposé un Form 144 signalant la vente proposée de 192,806 actions ordinaires pour une valeur totale de $717,238.32. Le dépôt indique que la vente est prévue aux alentours du 08/08/2025 sur le NASDAQ et désigne Morgan Stanley Smith Barney LLC comme courtier. Les actions ont été acquises le 12/10/2024 lors d'une opération de fusion/acquisition auprès de l'émetteur et ont été réglées en è. Le dossier indique 66,124,820 actions en circulation et mentionne Rien à signaler pour des ventes au cours des trois derniers mois.

Neuronetics, Inc. (STIM) hat ein Form 144 eingereicht, das einen geplanten Verkauf von 192,806 Stammaktien mit einem Gesamtmarktwert von $717,238.32 meldet. Die Einreichung gibt an, dass der Verkauf voraussichtlich am oder um den 08/08/2025 an der NASDAQ stattfinden wird und nennt Morgan Stanley Smith Barney LLC als Broker. Die Aktien wurden am 12/10/2024 im Rahmen einer ܲDz/ÜԲ󳾱-Transaktion vom Emittenten erworben und in Bar bezahlt. Das Formular verzeichnet 66,124,820 ausstehende Aktien und vermerkt Nichts zu melden für Verkäufe in den letzten drei Monaten.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Neuronetics (STIM) file in this Form 144?

The Form 144 notifies a proposed sale of 192,806 common shares with an aggregate market value of $717,238.32.

When and where is the sale expected to occur for STIM?

The filing lists the approximate sale date as 08/08/2025 and the venue as NASDAQ.

How were the shares being sold acquired according to the filing?

The shares were acquired on 12/10/2024 in a merger/acquisition transaction from the issuer and paid for in cash.

Who is the listed broker handling the proposed sale for STIM?

The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza 8th Floor New York NY 10004.

Were there any sales by the filer in the past three months reported?

The filing states Nothing to Report for securities sold during the past three months.
Neuronetics

NASDAQ:STIM

STIM Rankings

STIM Latest News

STIM Latest SEC Filings

STIM Stock Data

280.65M
35.35M
9.48%
62.58%
7.12%
Medical Devices
Surgical & Medical Instruments & Apparatus
United States
MALVERN